Traditional Chinese Medicine for Refractory Nephrotic Syndrome: Strategies and Promising Treatments
Open Access
- 4 January 2018
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2018 (1) , 8746349
Abstract
Refractory nephrotic syndrome (RNS) is an immune‐related kidney disease with poor clinical outcomes. Standard treatments include corticosteroids as the initial therapy and other immunosuppressants as second‐line options. A substantial proportion of patients with RNS are resistant to or dependent on immunosuppressive drugs and often experience unremitting edema and proteinuria, cycles of remission and relapse, and/or serious adverse events due to long‐term immunosuppression. Traditional Chinese medicine has a long history of treating complicated kidney diseases and holds great potential for providing effective treatments for RNS. This review describes the Chinese medical theories relating to the pathogenesis of RNS and discusses the strategies and treatment options using Chinese herbal medicine. Available preclinical and clinical evidence strongly supports the integration of traditional Chinese medicine and Western medicine for improving the outcome of RNS. Herbal medicine such as Astragalus membranaceus, Stephania tetrandra S. Moore, and Tripterygium wilfordii Hook F can serve as the alternative therapy when patients fail to respond to immunosuppression or as the complementary therapy to improve therapeutic efficacy and reduce side effects of immunosuppressive agents. Wuzhi capsules (Schisandra sphenanthera extract) with tacrolimus and tetrandrine with corticosteroids are two herb‐drug combinations that have shown great promise and warrant further studies.Keywords
Funding Information
- National Natural Science Foundation of China (81573907, JDZX2015194)
This publication has 59 references indexed in Scilit:
- Remission of Membranous Nephropathy After Therapy With Astragalus MembranaceusAmerican Journal of Kidney Diseases, 2010
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent PatientsClinical Journal of the American Society of Nephrology, 2009
- Tripterygium wilfordii Hook F Treatment for Idiopathic Refractory Nephrotic Syndrome in Adults: A Meta-AnalysisNephron Clinical Practice, 2009
- Schisandrol A from Schisandra chinensis Reverses P-Glycoprotein-Mediated Multidrug Resistance by Affecting Pgp-Substrate ComplexesPlanta Medica, 2007
- Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and traffickingBlood, 2005
- Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook FLeukemia & Lymphoma, 2001
- Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506Phytotherapy Research, 1999
- Identification of aristolochic acid in Chinese herbsThe Lancet, 1994
- In vitro Immunosuppressive Properties of the Plant Alkaloid TetrandrineInternational Archives of Allergy and Immunology, 1988